BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23365459)

  • 1. Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.
    Janelsins BM; Sumpter TL; Tkacheva OA; Rojas-Canales DM; Erdos G; Mathers AR; Shufesky WJ; Storkus WJ; Falo LD; Morelli AE; Larregina AT
    Blood; 2013 Apr; 121(15):2923-33. PubMed ID: 23365459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity.
    Janelsins BM; Mathers AR; Tkacheva OA; Erdos G; Shufesky WJ; Morelli AE; Larregina AT
    Blood; 2009 Mar; 113(13):3017-26. PubMed ID: 18987361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1- and Tc1-biased immune responses.
    Mathers AR; Tckacheva OA; Janelsins BM; Shufesky WJ; Morelli AE; Larregina AT
    J Immunol; 2007 Jun; 178(11):7006-17. PubMed ID: 17513750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing DCs by substance P.
    Takashima A
    Blood; 2013 Apr; 121(15):2815-6. PubMed ID: 23580632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.
    Robertson SJ; Lubick KJ; Freedman BA; Carmody AB; Best SM
    J Immunol; 2014 Mar; 192(6):2744-55. PubMed ID: 24532583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.
    Turnquist HR; Cardinal J; Macedo C; Rosborough BR; Sumpter TL; Geller DA; Metes D; Thomson AW
    Blood; 2010 Jun; 115(23):4758-69. PubMed ID: 20335217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation.
    Moulin V; Andris F; Thielemans K; Maliszewski C; Urbain J; Moser M
    J Exp Med; 2000 Aug; 192(4):475-82. PubMed ID: 10952717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone counteracts the immunostimulatory effects of triiodothyronine (T3) on dendritic cells.
    Montesinos MM; Alamino VA; Mascanfroni ID; Susperreguy S; Gigena N; Masini-Repiso AM; Rabinovich GA; Pellizas CG
    Steroids; 2012 Jan; 77(1-2):67-76. PubMed ID: 22056479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
    Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells.
    Lee JS; Kim SG; Kim HK; Lee TH; Jeong YI; Lee CM; Yoon MS; Na YJ; Suh DS; Park NC; Choi IH; Kim GY; Choi YH; Chung HY; Park YM
    J Cell Physiol; 2007 Feb; 210(2):385-97. PubMed ID: 17058260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses.
    Gao D; Mondal TK; Lawrence DA
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):69-79. PubMed ID: 17512567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
    Hüttner KG; Breuer SK; Paul P; Majdic O; Heitger A; Felzmann T
    Cancer Immunol Immunother; 2005 Jan; 54(1):67-77. PubMed ID: 15693141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells.
    Hackstein H; Morelli AE; Larregina AT; Ganster RW; Papworth GD; Logar AJ; Watkins SC; Falo LD; Thomson AW
    J Immunol; 2001 Jun; 166(12):7053-62. PubMed ID: 11390449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
    Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
    J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo.
    Raïch-Regué D; Rosborough BR; Watson AR; McGeachy MJ; Turnquist HR; Thomson AW
    J Immunol; 2015 May; 194(10):4767-76. PubMed ID: 25840913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo.
    Li Y; Chu N; Rostami A; Zhang GX
    J Immunol; 2006 Aug; 177(3):1679-88. PubMed ID: 16849477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
    Sundberg TB; Choi HG; Song JH; Russell CN; Hussain MM; Graham DB; Khor B; Gagnon J; O'Connell DJ; Narayan K; Dančík V; Perez JR; Reinecker HC; Gray NS; Schreiber SL; Xavier RJ; Shamji AF
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12468-73. PubMed ID: 25114223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.